Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
This bi-annual report is intended for our biotech clients. Questions addressed in our Medical Affairs Opportunity Assessments reports are: 1) What evidence will be (is still) needed)?; 2) What MSL structure is required?; and 3) What KOL engagement strategy makes sense?
This bi-annual report is intended for our biotech clients. Questions addressed in our Medical Affairs Opportunity Assessments reports are: 1) What evidence will be (is still) needed)?; 2) What MSL structure is required?; and 3) What KOL engagement strategy makes sense?